search
Back to results

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine (SUMMIT)

Primary Purpose

Migraine, Migraine With Aura, Migraine Without Aura

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Dihydroergotamine
Placebo
Sponsored by
Satsuma Pharmaceuticals, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Migraine focused on measuring dihydroergotamine, dihydroergotamine mesylate, migraine

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Key Inclusion Criteria:

  • Males or females, 18-65 years of age at the time of Screening Visit
  • Subject has at least 1-year history of migraines (with or without aura), according to the International Classification of Headache Disorder, 3rd Edition (ICHD3)

Key Exclusion Criteria:

  • Pregnant or breast-feeding women
  • Women of child-bearing potential not using or not willing to use highly effective contraception.
  • Diagnosis of headache conditions other than migraine with or without aura, including diagnosis of basilar or hemiplegic migraines or cluster headache.
  • History of coronary artery disease, coronary artery vasospasm (including Printz-metals' angina), clinically significant arrhythmia or, peripheral vascular disease, ischemic disease (e.g. Raynaud's syndrome, ischemic bowel syndrome, angina pectoris, myocardial infarction, or documented silent ischemia); percutaneous coronary intervention, or cardiac surgery.
  • History of cerebrovascular disease, including but not limited to stroke, transient ischemic attack, cerebral hemorrhage, subarachnoid hemorrhage.
  • Diagnosis of major depression with current symptoms, psychosis, alcohol abuse or dependence, drug abuse or dependence, major psychiatric conditions (e.g. schizophrenia, psychosis or Bipolar disorder), dementia. Other significant neurological or psychiatric disorders (including other pain syndromes or risk of suicide) that in the opinion of the investigator might interfere with study participation and assessments or subject safety.
  • Any clinically significant symptoms or conditions, including but not limited to central nervous system (e.g., seizures), cardiac, pulmonary, metabolic, renal, hepatic or gastrointestinal conditions or history of such conditions that, in the opinion of the investigator might interfere with study assessments or safety of participant.

Sites / Locations

  • MD First Research
  • Elite Clinical Studies
  • Alliance For Multispecialty Research
  • Cognitive Clinical Trials, LLC
  • Clinedge, LLC
  • ERG Clinical
  • Hope Clinical Research
  • Wr-Pri, Llc
  • Neuro-Pain Medical Center Ince
  • Estudy Site - La Mesa
  • Wr-Pri Llc
  • Downtown LA Research Center
  • Clinical Research Institute
  • Wr-Pri Llc
  • Artemis Institute for Clinical Research - San Diego
  • WR-MCCR
  • Acclaim Clinical Research
  • National Research Institute, A Clinical Research Organization
  • Alpine Clinical Research Center, Inc
  • Clinedge, LLC
  • Neurology Offices of South Florida
  • Velocity Clinical Research, Hallendale Beach
  • Infinity Clinical Research, LLC
  • Elite Research Network, LLC a Florida LLC
  • Clinical Neuroscience Solutions, Inc
  • Elite Research Network LLC a Florida LLC
  • Multi-Specialty Research Associates
  • Clinicloud
  • Next Phase Research
  • Applemed Research Group
  • Biotech Pharmaceuticals Group LLC
  • Novel Clinical Research Center LLC
  • Floridian Research
  • Behavioral Clinical Research
  • Accel-Orange City
  • CNS Health Care Orlando
  • Complete Health Research
  • Oveido Medical Research
  • Santos Research Center
  • VICIS Clinical Research, Inc
  • Palm Beach Research
  • Conquest Research, LLC
  • Delricht
  • I-Research Atlanta
  • Alpha Clinical Research Georgia
  • Clin-Edge, LLC
  • I Research Savannah
  • Advanced Clinical Research
  • CIS Research
  • Medisphere Medical Research Center
  • PMG Research Inc
  • Meridian Clinical Research
  • Integrated Clinical Trial SVC
  • Alliance For Multispecialty Research
  • Louisville Metabolic & Atherosclerosis Research Center
  • Delricht Research
  • Crescent City Headache and Neurology
  • Delricht
  • Alliance for Multispecialty Research
  • Delricht-New Orleans
  • Boston Clinical Trials
  • BTC of New Bedford
  • Northeast Medical Research Associates
  • "Medvadis Research Corp, Llc @Boston Paincare Center "
  • MHNI
  • Minneapolis Clinic of Neurology
  • Delricht
  • Alliance for Multispecialty Research
  • Montana Medical Research, Inc
  • Skyline Medical Center, PC CCT Research
  • Cognitive Clinical Trials, LLC
  • Quality Clinical Research, Inc
  • Excel Clinical Research
  • Wake Research-Clinical Research Center of Nevada LLC
  • Clinedge LLC
  • Albuquerque Clinical Trials
  • Integrative Clinical Trials
  • SPRI Clinical Trials, LLC
  • North Suffolk Neurology
  • Drug Trials America
  • Central New York Clinical Research
  • Upstate Clinical Research Associates
  • PMG Research of Charlotte
  • Onsite Clinical
  • Headache Wellness Center - Greensboro
  • Pharmquest, LLC
  • Peters Medical Research
  • North Carolina Clinical Research
  • PMG Research, Inc
  • PMG Research of Wilmington, LLC
  • PMG Research Inc
  • Plains Clinical Research
  • CTI Clinical Research Center
  • Aventiv Research
  • Aventiv Research, Inc
  • OK Clinical Research
  • Elite Research Network, LLC a Florida LLC
  • Hightower Clinical
  • Delricht Research
  • Tekton Research
  • Suburban Research Associates
  • Ocean State Clinical Research Partners
  • Velocity Clinical Research.- Providence
  • Clinedge LLC - Clinical Trials SSC
  • Tribe CR
  • Coastal Carolina Research Center Inc
  • Hillcrest Clinical Research
  • Internal Medicine and Pediatric Associates of Bristol, PC
  • New Phase Research & Development
  • Clinical Research Associates, Inc
  • Future Search Trials of Neurology
  • Premier Family Physicians
  • Discoveresearch
  • Future Search Trials of Dallas, LP
  • Cedar Health Research, LLC
  • North Texas Institute of Neurology
  • Epic Clinical Research
  • DM Clinical Research
  • Village Health Partners
  • Sun Research
  • DM Clinical Research
  • Advanced Research Institute
  • Charlottesville Medical Research
  • Alliance For Multispecialty Research
  • Tidewater Integrated Medical Research
  • Northwest Clinical Research Center
  • Seattle Womens

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

STS101

STS101 Placebo

Arm Description

STS101 (dihydroergotamine nasal powder)

STS101 Placebo

Outcomes

Primary Outcome Measures

Percentage of Subjects With Freedom From Migraine Headache Pain at 2 Hours Post Dose
The subject's rating was documented on a four-point scale from no pain (= 0), mild pain (= 1), moderate pain (= 2) to severe pain (= 3). Pain freedom means the pain went from moderate (2) or severe (3) to no pain (0).
Percentage of Subjects With Freedom From Most-Bothersome Symptom at 2 Hours Post Dose
Subjects were prompted to document the presence of 3 symptoms (photophobia, phonophobia, and nausea) immediately before study drug administration and during the treated migraine attack.

Secondary Outcome Measures

Percentage of Subjects With Relief From Migraine Headache Pain at 2 Hours Post Dose
The subject's rating was documented on a four-point scale from no pain (= 0), mild pain (= 1), moderate pain (= 2) to severe pain (= 3). Pain relief means the pain went from moderate (2) or severe (3) to mild pain (1) or no pain (0).

Full Information

First Posted
June 17, 2021
Last Updated
June 29, 2023
Sponsor
Satsuma Pharmaceuticals, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT04940390
Brief Title
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine
Acronym
SUMMIT
Official Title
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
June 30, 2021 (Actual)
Primary Completion Date
October 13, 2022 (Actual)
Study Completion Date
October 26, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Satsuma Pharmaceuticals, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Study STS101-007 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.
Detailed Description
Study STS101-007 is a multi-center, single-dose, randomized, double-blind, placebo-controlled, parallel group study in subjects with acute migraine (ages 18 to 65 years).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Migraine, Migraine With Aura, Migraine Without Aura
Keywords
dihydroergotamine, dihydroergotamine mesylate, migraine

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
1591 (Actual)

8. Arms, Groups, and Interventions

Arm Title
STS101
Arm Type
Experimental
Arm Description
STS101 (dihydroergotamine nasal powder)
Arm Title
STS101 Placebo
Arm Type
Experimental
Arm Description
STS101 Placebo
Intervention Type
Drug
Intervention Name(s)
Dihydroergotamine
Other Intervention Name(s)
Dihydroergotamine Mesylate
Intervention Description
Dihydroergotamine is a semi-synthetic derivative of ergotamine tartrate.
Intervention Type
Drug
Intervention Name(s)
Placebo
Other Intervention Name(s)
STS101 Placebo
Intervention Description
Placebo for STS101
Primary Outcome Measure Information:
Title
Percentage of Subjects With Freedom From Migraine Headache Pain at 2 Hours Post Dose
Description
The subject's rating was documented on a four-point scale from no pain (= 0), mild pain (= 1), moderate pain (= 2) to severe pain (= 3). Pain freedom means the pain went from moderate (2) or severe (3) to no pain (0).
Time Frame
2 Hours Post-Dose
Title
Percentage of Subjects With Freedom From Most-Bothersome Symptom at 2 Hours Post Dose
Description
Subjects were prompted to document the presence of 3 symptoms (photophobia, phonophobia, and nausea) immediately before study drug administration and during the treated migraine attack.
Time Frame
2 Hours Post-Dose
Secondary Outcome Measure Information:
Title
Percentage of Subjects With Relief From Migraine Headache Pain at 2 Hours Post Dose
Description
The subject's rating was documented on a four-point scale from no pain (= 0), mild pain (= 1), moderate pain (= 2) to severe pain (= 3). Pain relief means the pain went from moderate (2) or severe (3) to mild pain (1) or no pain (0).
Time Frame
2 Hours Post Dose

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Key Inclusion Criteria: Males or females, 18-65 years of age at the time of Screening Visit Subject has at least 1-year history of migraines (with or without aura), according to the International Classification of Headache Disorder, 3rd Edition (ICHD3) Key Exclusion Criteria: Pregnant or breast-feeding women Women of child-bearing potential not using or not willing to use highly effective contraception. Diagnosis of headache conditions other than migraine with or without aura, including diagnosis of basilar or hemiplegic migraines or cluster headache. History of coronary artery disease, coronary artery vasospasm (including Printz-metals' angina), clinically significant arrhythmia or, peripheral vascular disease, ischemic disease (e.g. Raynaud's syndrome, ischemic bowel syndrome, angina pectoris, myocardial infarction, or documented silent ischemia); percutaneous coronary intervention, or cardiac surgery. History of cerebrovascular disease, including but not limited to stroke, transient ischemic attack, cerebral hemorrhage, subarachnoid hemorrhage. Diagnosis of major depression with current symptoms, psychosis, alcohol abuse or dependence, drug abuse or dependence, major psychiatric conditions (e.g. schizophrenia, psychosis or Bipolar disorder), dementia. Other significant neurological or psychiatric disorders (including other pain syndromes or risk of suicide) that in the opinion of the investigator might interfere with study participation and assessments or subject safety. Any clinically significant symptoms or conditions, including but not limited to central nervous system (e.g., seizures), cardiac, pulmonary, metabolic, renal, hepatic or gastrointestinal conditions or history of such conditions that, in the opinion of the investigator might interfere with study assessments or safety of participant.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Detlef Albrecht, MD
Organizational Affiliation
Satsuma Pharmaceuticals, Inc.
Official's Role
Study Chair
Facility Information:
Facility Name
MD First Research
City
Chandler
State/Province
Arizona
ZIP/Postal Code
85286
Country
United States
Facility Name
Elite Clinical Studies
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85018
Country
United States
Facility Name
Alliance For Multispecialty Research
City
Tempe
State/Province
Arizona
ZIP/Postal Code
85283
Country
United States
Facility Name
Cognitive Clinical Trials, LLC
City
Tempe
State/Province
Arizona
ZIP/Postal Code
85283
Country
United States
Facility Name
Clinedge, LLC
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85704
Country
United States
Facility Name
ERG Clinical
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72211
Country
United States
Facility Name
Hope Clinical Research
City
Canoga Park
State/Province
California
ZIP/Postal Code
91303
Country
United States
Facility Name
Wr-Pri, Llc
City
Encino
State/Province
California
ZIP/Postal Code
91316
Country
United States
Facility Name
Neuro-Pain Medical Center Ince
City
Fresno
State/Province
California
ZIP/Postal Code
93710
Country
United States
Facility Name
Estudy Site - La Mesa
City
La Mesa
State/Province
California
ZIP/Postal Code
91942
Country
United States
Facility Name
Wr-Pri Llc
City
Los Alamitos
State/Province
California
ZIP/Postal Code
90720
Country
United States
Facility Name
Downtown LA Research Center
City
Los Angeles
State/Province
California
ZIP/Postal Code
90017
Country
United States
Facility Name
Clinical Research Institute
City
Los Angeles
State/Province
California
ZIP/Postal Code
90048
Country
United States
Facility Name
Wr-Pri Llc
City
Newport Beach
State/Province
California
ZIP/Postal Code
92660
Country
United States
Facility Name
Artemis Institute for Clinical Research - San Diego
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
WR-MCCR
City
San Diego
State/Province
California
ZIP/Postal Code
92108
Country
United States
Facility Name
Acclaim Clinical Research
City
San Diego
State/Province
California
ZIP/Postal Code
92120
Country
United States
Facility Name
National Research Institute, A Clinical Research Organization
City
Santa Ana
State/Province
California
ZIP/Postal Code
92704
Country
United States
Facility Name
Alpine Clinical Research Center, Inc
City
Boulder
State/Province
Colorado
ZIP/Postal Code
80301
Country
United States
Facility Name
Clinedge, LLC
City
Cromwell
State/Province
Connecticut
ZIP/Postal Code
06416
Country
United States
Facility Name
Neurology Offices of South Florida
City
Boca Raton
State/Province
Florida
ZIP/Postal Code
33428
Country
United States
Facility Name
Velocity Clinical Research, Hallendale Beach
City
Hallandale Beach
State/Province
Florida
ZIP/Postal Code
33009
Country
United States
Facility Name
Infinity Clinical Research, LLC
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33024
Country
United States
Facility Name
Elite Research Network, LLC a Florida LLC
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32216
Country
United States
Facility Name
Clinical Neuroscience Solutions, Inc
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32256
Country
United States
Facility Name
Elite Research Network LLC a Florida LLC
City
Jupiter
State/Province
Florida
ZIP/Postal Code
33458
Country
United States
Facility Name
Multi-Specialty Research Associates
City
Lake City
State/Province
Florida
ZIP/Postal Code
32055
Country
United States
Facility Name
Clinicloud
City
Maitland
State/Province
Florida
ZIP/Postal Code
32751
Country
United States
Facility Name
Next Phase Research
City
Miami
State/Province
Florida
ZIP/Postal Code
33144
Country
United States
Facility Name
Applemed Research Group
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Facility Name
Biotech Pharmaceuticals Group LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Facility Name
Novel Clinical Research Center LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33173
Country
United States
Facility Name
Floridian Research
City
Miami
State/Province
Florida
ZIP/Postal Code
33179
Country
United States
Facility Name
Behavioral Clinical Research
City
North Miami
State/Province
Florida
ZIP/Postal Code
33161
Country
United States
Facility Name
Accel-Orange City
City
Orange City
State/Province
Florida
ZIP/Postal Code
32763
Country
United States
Facility Name
CNS Health Care Orlando
City
Orlando
State/Province
Florida
ZIP/Postal Code
32801
Country
United States
Facility Name
Complete Health Research
City
Ormond Beach
State/Province
Florida
ZIP/Postal Code
32174
Country
United States
Facility Name
Oveido Medical Research
City
Oviedo
State/Province
Florida
ZIP/Postal Code
32765
Country
United States
Facility Name
Santos Research Center
City
Tampa
State/Province
Florida
ZIP/Postal Code
33603
Country
United States
Facility Name
VICIS Clinical Research, Inc
City
Tampa
State/Province
Florida
ZIP/Postal Code
33615
Country
United States
Facility Name
Palm Beach Research
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33409
Country
United States
Facility Name
Conquest Research, LLC
City
Winter Park
State/Province
Florida
ZIP/Postal Code
32789
Country
United States
Facility Name
Delricht
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30329
Country
United States
Facility Name
I-Research Atlanta
City
Decatur
State/Province
Georgia
ZIP/Postal Code
30030
Country
United States
Facility Name
Alpha Clinical Research Georgia
City
Johns Creek
State/Province
Georgia
ZIP/Postal Code
30022
Country
United States
Facility Name
Clin-Edge, LLC
City
Marietta
State/Province
Georgia
ZIP/Postal Code
30060
Country
United States
Facility Name
I Research Savannah
City
Savannah
State/Province
Georgia
ZIP/Postal Code
31405
Country
United States
Facility Name
Advanced Clinical Research
City
Meridian
State/Province
Idaho
ZIP/Postal Code
83642
Country
United States
Facility Name
CIS Research
City
Wauconda
State/Province
Illinois
ZIP/Postal Code
60084
Country
United States
Facility Name
Medisphere Medical Research Center
City
Evansville
State/Province
Indiana
ZIP/Postal Code
47714
Country
United States
Facility Name
PMG Research Inc
City
Ames
State/Province
Iowa
ZIP/Postal Code
50010
Country
United States
Facility Name
Meridian Clinical Research
City
Sioux City
State/Province
Iowa
ZIP/Postal Code
51106
Country
United States
Facility Name
Integrated Clinical Trial SVC
City
West Des Moines
State/Province
Iowa
ZIP/Postal Code
50265
Country
United States
Facility Name
Alliance For Multispecialty Research
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40509
Country
United States
Facility Name
Louisville Metabolic & Atherosclerosis Research Center
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40213
Country
United States
Facility Name
Delricht Research
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70817
Country
United States
Facility Name
Crescent City Headache and Neurology
City
Chalmette
State/Province
Louisiana
ZIP/Postal Code
70043
Country
United States
Facility Name
Delricht
City
Covington
State/Province
Louisiana
ZIP/Postal Code
70433
Country
United States
Facility Name
Alliance for Multispecialty Research
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70119
Country
United States
Facility Name
Delricht-New Orleans
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70124
Country
United States
Facility Name
Boston Clinical Trials
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02131
Country
United States
Facility Name
BTC of New Bedford
City
New Bedford
State/Province
Massachusetts
ZIP/Postal Code
02740
Country
United States
Facility Name
Northeast Medical Research Associates
City
North Dartmouth
State/Province
Massachusetts
ZIP/Postal Code
02747
Country
United States
Facility Name
"Medvadis Research Corp, Llc @Boston Paincare Center "
City
Waltham
State/Province
Massachusetts
ZIP/Postal Code
02451
Country
United States
Facility Name
MHNI
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48104
Country
United States
Facility Name
Minneapolis Clinic of Neurology
City
Burnsville
State/Province
Minnesota
ZIP/Postal Code
55337
Country
United States
Facility Name
Delricht
City
Gulfport
State/Province
Mississippi
ZIP/Postal Code
39503
Country
United States
Facility Name
Alliance for Multispecialty Research
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64114
Country
United States
Facility Name
Montana Medical Research, Inc
City
Missoula
State/Province
Montana
ZIP/Postal Code
59808
Country
United States
Facility Name
Skyline Medical Center, PC CCT Research
City
Elkhorn
State/Province
Nebraska
ZIP/Postal Code
68022
Country
United States
Facility Name
Cognitive Clinical Trials, LLC
City
Fremont
State/Province
Nebraska
ZIP/Postal Code
68025
Country
United States
Facility Name
Quality Clinical Research, Inc
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68114
Country
United States
Facility Name
Excel Clinical Research
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89109
Country
United States
Facility Name
Wake Research-Clinical Research Center of Nevada LLC
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89118
Country
United States
Facility Name
Clinedge LLC
City
North Las Vegas
State/Province
Nevada
ZIP/Postal Code
89030
Country
United States
Facility Name
Albuquerque Clinical Trials
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87102
Country
United States
Facility Name
Integrative Clinical Trials
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11229
Country
United States
Facility Name
SPRI Clinical Trials, LLC
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11235
Country
United States
Facility Name
North Suffolk Neurology
City
Commack
State/Province
New York
ZIP/Postal Code
11725
Country
United States
Facility Name
Drug Trials America
City
Hartsdale
State/Province
New York
ZIP/Postal Code
10530
Country
United States
Facility Name
Central New York Clinical Research
City
Manlius
State/Province
New York
ZIP/Postal Code
13104
Country
United States
Facility Name
Upstate Clinical Research Associates
City
Williamsville
State/Province
New York
ZIP/Postal Code
14221
Country
United States
Facility Name
PMG Research of Charlotte
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28209
Country
United States
Facility Name
Onsite Clinical
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28277
Country
United States
Facility Name
Headache Wellness Center - Greensboro
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27405
Country
United States
Facility Name
Pharmquest, LLC
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27408
Country
United States
Facility Name
Peters Medical Research
City
High Point
State/Province
North Carolina
ZIP/Postal Code
27262
Country
United States
Facility Name
North Carolina Clinical Research
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27607
Country
United States
Facility Name
PMG Research, Inc
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27609
Country
United States
Facility Name
PMG Research of Wilmington, LLC
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28401
Country
United States
Facility Name
PMG Research Inc
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Facility Name
Plains Clinical Research
City
South West Fargo
State/Province
North Dakota
ZIP/Postal Code
58104
Country
United States
Facility Name
CTI Clinical Research Center
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45212
Country
United States
Facility Name
Aventiv Research
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43213
Country
United States
Facility Name
Aventiv Research, Inc
City
Dublin
State/Province
Ohio
ZIP/Postal Code
43016
Country
United States
Facility Name
OK Clinical Research
City
Edmond
State/Province
Oklahoma
ZIP/Postal Code
73034
Country
United States
Facility Name
Elite Research Network, LLC a Florida LLC
City
Norman
State/Province
Oklahoma
ZIP/Postal Code
73072
Country
United States
Facility Name
Hightower Clinical
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73134
Country
United States
Facility Name
Delricht Research
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74133
Country
United States
Facility Name
Tekton Research
City
Yukon
State/Province
Oklahoma
ZIP/Postal Code
73099
Country
United States
Facility Name
Suburban Research Associates
City
Media
State/Province
Pennsylvania
ZIP/Postal Code
19063
Country
United States
Facility Name
Ocean State Clinical Research Partners
City
Lincoln
State/Province
Rhode Island
ZIP/Postal Code
02865
Country
United States
Facility Name
Velocity Clinical Research.- Providence
City
Warwick
State/Province
Rhode Island
ZIP/Postal Code
02886
Country
United States
Facility Name
Clinedge LLC - Clinical Trials SSC
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29406
Country
United States
Facility Name
Tribe CR
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29607
Country
United States
Facility Name
Coastal Carolina Research Center Inc
City
North Charleston
State/Province
South Carolina
ZIP/Postal Code
29405
Country
United States
Facility Name
Hillcrest Clinical Research
City
Simpsonville
State/Province
South Carolina
ZIP/Postal Code
29681
Country
United States
Facility Name
Internal Medicine and Pediatric Associates of Bristol, PC
City
Bristol
State/Province
Tennessee
ZIP/Postal Code
37620
Country
United States
Facility Name
New Phase Research & Development
City
Knoxville
State/Province
Tennessee
ZIP/Postal Code
37909
Country
United States
Facility Name
Clinical Research Associates, Inc
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37203
Country
United States
Facility Name
Future Search Trials of Neurology
City
Austin
State/Province
Texas
ZIP/Postal Code
78731
Country
United States
Facility Name
Premier Family Physicians
City
Austin
State/Province
Texas
ZIP/Postal Code
78735
Country
United States
Facility Name
Discoveresearch
City
Bryan
State/Province
Texas
ZIP/Postal Code
77802
Country
United States
Facility Name
Future Search Trials of Dallas, LP
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
Facility Name
Cedar Health Research, LLC
City
Dallas
State/Province
Texas
ZIP/Postal Code
75251
Country
United States
Facility Name
North Texas Institute of Neurology
City
Frisco
State/Province
Texas
ZIP/Postal Code
75034
Country
United States
Facility Name
Epic Clinical Research
City
Lewisville
State/Province
Texas
ZIP/Postal Code
75057
Country
United States
Facility Name
DM Clinical Research
City
Magnolia
State/Province
Texas
ZIP/Postal Code
77355
Country
United States
Facility Name
Village Health Partners
City
Plano
State/Province
Texas
ZIP/Postal Code
75024
Country
United States
Facility Name
Sun Research
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78215
Country
United States
Facility Name
DM Clinical Research
City
Tomball
State/Province
Texas
ZIP/Postal Code
77375
Country
United States
Facility Name
Advanced Research Institute
City
Ogden
State/Province
Utah
ZIP/Postal Code
84405
Country
United States
Facility Name
Charlottesville Medical Research
City
Charlottesville
State/Province
Virginia
ZIP/Postal Code
22911
Country
United States
Facility Name
Alliance For Multispecialty Research
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23502
Country
United States
Facility Name
Tidewater Integrated Medical Research
City
Virginia Beach
State/Province
Virginia
ZIP/Postal Code
23454
Country
United States
Facility Name
Northwest Clinical Research Center
City
Bellevue
State/Province
Washington
ZIP/Postal Code
98007
Country
United States
Facility Name
Seattle Womens
City
Seattle
State/Province
Washington
ZIP/Postal Code
98105
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine

We'll reach out to this number within 24 hrs